Tick-borne encephalitis

Active Research Protocols

  1. 09-I-0246 – A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-Borne Encephalitis (TBE) for NIAID Workers Manipulating Tick-Borne Encephalitis Virus (TBEV) in the Laboratory
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014